Cochlear Limited SWOT Analysis

Published in Pharma and Healthcare category by MBA Skool Team

Cochlear Limited is one of the leading brands in the pharma and healthcare sector. Cochlear Limited SWOT analysis evaluates the brand by its strengths & weaknesses which are the internal factors along with opportunities & threats which are the external factors. Let us start the SWOT Analysis of Cochlear Limited:

Cochlear Limited Strengths

  1. COH is investing in research to redesign devices to enable manufacturing scale-up from a cottage industry to a production line
  2. Management is also building the infrastructure to handle more revenue by investing in marketing and sales resources. 
  3. COH has a reputation of delivering the most reliable and safest implantable device provides strong brand awareness with hearing specialists
  4. The company has over 2700 employees in over 25 countries
  5. One of the most recognised companies in Australia

Above are the strengths in the SWOT Analysis of Cochlear Limited. The strengths of Cochlear Limited looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.

Cochlear Limited Weaknesses

  1. Untapped markets due to lack of relationship with suppliers and other partners
  2. Growing competition means limited market share
  3. Huge investments in research and development means financial challenge

These were the weaknesses in the Cochlear Limited SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.

Cochlear Limited Opportunities

  1. Less than 10% of the profoundly deaf have an implantable hearing device, management expect they can exploit the immaturity of the global market
  2. With increasing aging US population is expected to drive demand for hearing aids and assistive listening devices
  3. Collaborative tie ups with hospitals, clinics, medical professionals etc.

Above we covered the opportunities in Cochlear Limited SWOT Analysis. The opportunities for any brand can include prospects of future growth.

Cochlear Limited Threats

  1. Competition from local hearing clinics
  2. The products require constant innovation to maintain the edge over the competitors

The threats in the SWOT Analysis of Cochlear Limited are as mentioned above. The threats for any business can be external factors which can negatively impact its business.

Hence this concludes the Cochlear Limited SWOT analysis.

Continue reading more about the brand/company.

About Cochlear Limited

The table below gives the brand overview along with its target market, segmentation, positioning & USP

Cochlear Limited Overview
Parent Company

Cochlear Limited

Category

Biotechnology

Sector

Pharma and Healthcare

Tagline/ Slogan

Hear now. And always

USP

Designs, manufactures and supplies the Nucleus cochlear implant, the Hybridelectro-acoustic implant and the Baha bone conduction implant

Cochlear Limited STP
Segmentation

People with auditory problems

Target Market

Healthcare professionals operating in these areas, individuals with hearing troubles

Positioning

A cochlear implant is an established, effective and long-term solution for people with moderate to profound hearing loss. Cochlear pioneered the implant technology and is still the world’s industry leader.

 

This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Browse marketing analysis of more brands and companies similar to Cochlear Limited. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.

Continue Reading:


The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin